Daily Sepsis Research Analysis
Analyzed 32 papers and selected 3 impactful papers.
Summary
Analyzed 32 papers and selected 3 impactful articles.
Selected Articles
1. Phage-steering permits antibody-mediated clearance of E. coli K1 from the gut.
K1-specific phages drove capsule loss in E. coli K1, exposing O-antigen and rendering bacteria susceptible to vaccine-induced intestinal IgA; adding the probiotic E. coli Nissle enabled competitive exclusion. In a murine vertical transmission model, maternal vaccination plus phage therapy protected 77% of pups, outperforming either intervention alone.
Impact: Introduces a mechanistically novel, combinatorial strategy (phage-steering plus vaccination) to decolonize a major neonatal sepsis pathogen and prevent vertical transmission.
Clinical Implications: If translated to humans, maternal decolonization using targeted phages plus O-antigen vaccination (with/without probiotics) could reduce neonatal sepsis by preventing E. coli K1 transmission. Regulatory and safety frameworks for combined phage–vaccine approaches will be essential.
Key Findings
- K1-specific phages selected capsule-less E. coli K1 mutants exposing O-antigen.
- Vaccine-induced intestinal IgA against O-antigen enabled immune clearance of phage-steered mutants.
- Probiotic E. coli Nissle competitively excluded E. coli K1 after phage-steering and vaccination.
- Maternal vaccination plus phages protected 77% of pups from E. coli K1 transmission; either alone was insufficient.
Methodological Strengths
- In vivo gut colonization and vertical transmission models enabling causal inference of interventions.
- Mechanistic linkage from phage-driven capsule loss to IgA susceptibility and microbial competition.
Limitations
- Preclinical murine study; generalizability to humans and diverse E. coli strains is uncertain.
- Safety, durability of decolonization, and regulatory pathways for combined phage–vaccine strategies remain to be established.
Future Directions: Conduct human colonization/decolonization studies in pregnant populations, optimize phage cocktails and O-antigen-targeted vaccines, assess microbiome impacts and resistance dynamics, and evaluate maternal–infant outcomes in early-phase trials.
Escherichia coli (E. coli) strains expressing the capsule serotype K1 (E. coli K1) are a prevalent cause of neonatal sepsis and meningitis. The gut microbiota of healthy adults is a natural reservoir of E. coli K1, from which it can spread to extra-intestinal sites or be transmitted from mother to infant during birth. Accordingly, shifting gut colonization from potentially pathogenic E. coli strains to more benign strains could reduce the risk of disease. Here, we leverage selective pressures exerted by bacteriophage and mucosal antibodies to limit gut colonization by E. coli K1 and prevent its transmission. K1-specific bacteriophages (phages) rapidly drive a within-host evolution of capsule-less mutants with exposed surface O-antigens. These mutants become susceptible to vaccine-induced intestinal IgA targeting the bacterial O-antigen, allowing competitive exclusion by the probiotic strain E. coli Nissle. In a murine vertical transmission model, 77% of pups were protected from transmission of E. coli K1 when the mother was vaccinated and treated with phages, whereas E. coli K1 was detected in most pups by day 10 of life when the mother received vaccination or phage therapy alone. Although the high diversity of E. coli makes generalization challenging, combining vaccination with phage-steering represents a promising approach for further exploration in eliminating infectious reservoirs.
2. From proteomics to colloidal gold tests for urinary thrombomodulin: a prospective cohort study on accurate sepsis screening.
Urine proteomics identified thrombomodulin as a sepsis biomarker; urinary TM decreased with increasing severity, while blood TM increased. A colloidal gold urine strip achieved 86% sensitivity and 78% specificity for sepsis screening and an AUC of 0.92 (93% sensitivity, 81% specificity) for septic shock diagnosis and 28-day mortality prediction.
Impact: Demonstrates a practical, non-invasive point-of-care test that could accelerate sepsis identification and risk stratification, especially where rapid blood testing is limited.
Clinical Implications: Urinary TM strip testing could support early sepsis screening and identify patients at high risk of septic shock and 28-day mortality, informing triage and escalation pathways.
Key Findings
- Urine DIA proteomics identified 178 DEPs; urinary thrombomodulin emerged as a key biomarker.
- Urinary TM decreased with severity, whereas blood TM increased across healthy, sepsis, and septic shock groups.
- At 11.85 TU/mL, urinary TM predicted septic shock and 28-day mortality with AUC 0.92 (93% sensitivity, 81% specificity).
- A colloidal gold urine strip achieved 86.1% sensitivity and 77.6% specificity for sepsis screening with agreement to Sepsis 3.0 criteria.
Methodological Strengths
- Prospective design with discovery (proteomics), validation (serum/urine), and point-of-care implementation.
- Robust diagnostic evaluation including ROC thresholds, Kappa agreement, and McNemar testing against immunofluorescence.
Limitations
- Single-center cohorts with modest sample sizes; external generalizability requires multicenter validation.
- Potential confounding by renal function and urine concentration; dynamic serial testing beyond single thresholds was limited.
Future Directions: Validate urinary TM performance across diverse ICUs and renal function strata, integrate serial measurements into triage pathways, and assess clinical/economic impact in implementation trials.
BACKGROUND: To develop a new non-invasive screening method for sepsis by detecting urine samples. METHODS: A prospective study was conducted to collect urine samples from a cohort of 22 individuals diagnosed with sepsis and admitted to the Intensive Care Unit (ICU) of a university-affiliated teaching hospital in China. Utilizing proteomic and bioinformatics analyses, we sought to identify potential biomarkers indicative of sepsis. These biomarkers were subsequently validated using serum and urine samples from 31 patients with septic shock, 83 patients with sepsis, and 50 healthy controls. Receiver operating characteristic (ROC) curves were employed to determine the optimal cutoff values for these biomarkers. Based on the diagnostic thresholds derived from ROC analysis, colloidal gold test strips were developed and applied to screen a cohort of 92 ICU patients. The diagnostic accuracy of these test strips was rigorously assessed by comparing their results with those from immunofluorescence assays. RESULTS: Data-independent acquisition (DIA) proteomics analysis of urine samples identified 2,846 proteins, with stringent filtration criteria (fold change > 2 or < 0.5, P-value < 0.05) yielding 178 differentially expressed proteins (DEPs). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis revealed significant enrichment of DEPs in pathways associated with "cell adhesion molecules," "lysosomes," and metabolic processes. The Boruta algorithm, integrating Random Forest and Support Vector Machine (SVM) analysis, identified urinary thrombomodulin (TM) as a key candidate molecule. Immunofluorescence analysis for validation trial showed rising trend in blood TM levels across disease severities: 7.55 (6.58-8.72) TU/mL in healthy controls, 10.08 (8.00-14.15) TU/mL in general sepsis, and 12.30 (7.54-18.68) TU/mL in septic shock. Conversely, urinary TM levels decreased: 23.65 (18.08-31.06) TU/mL, 17.70 (13.80-28.80) TU/mL, and 5.84 (4.00-11.59) TU/mL, respectively. At a urinary TM threshold of 15.46 TU/mL, the ROC AUC for sepsis diagnosis is 0.72, with 57% sensitivity and 88% specificity (P<0.05), showing no significant difference comparable to blood TM (P>0.05). For septic shock diagnosis and 28-day mortality prediction, a urinary TM threshold of 11.85 TU/mL yields an ROC AUC of 0.92, with 93% sensitivity and 81% specificity, outperforming blood TM (P<0.05). A urinary TM colloidal gold test strip, which turns red at TM levels above 15.46 TU/mL, was developed and validated on urine samples from 43 sepsis and 49 non-sepsis patients, achieving 86.1% sensitivity, 77.6% specificity and an overall accuracy of 81.5% for sepsis diagnosis. The Kappa test validated the concordance of the colloidal gold strip test with Sepsis 3.0 diagnostic criteria, while the McNemar test indicated no significant difference in sepsis diagnosis efficacy between the strip test and chemiluminescent immunofluorescence (p=0.228). CONCLUSIONS: The utilization of urine test strips for the detection of TM offers a precise, convenient, and practical method for the screening of sepsis.
3. [Relationship between pathogen load kinetics of common Gram-negative bacteria detected by droplet digital polymerase chain reaction and prognosis of patients with suspected bloodstream infections].
In suspected BSI, higher initial ddPCR pathogen loads correlated with hs-CRP, PCT, lactate, APACHE II, and SOFA. A ≥50% decrease in pathogen load by day 7 was associated with reductions in inflammation and severity scores and improved 28-day survival, whereas non-decrease was linked to greater vasopressor/ventilation use and higher mortality.
Impact: Provides prospective evidence that ddPCR-based pathogen load kinetics reflect treatment response and prognosis, supporting precision monitoring beyond binary culture results.
Clinical Implications: Serial ddPCR quantification may inform early escalation/de-escalation and prognostication in Gram-negative BSI, complementing cultures and routine biomarkers.
Key Findings
- Initial ddPCR pathogen load correlated with hs-CRP, PCT, lactate, APACHE II, and SOFA at enrollment.
- ≥50% decrease in pathogen load by day 7 associated with improved inflammatory markers and lower APACHE II/SOFA.
- Non-decrease group required more vasopressors/ventilation and had higher 28-day mortality; survival curves significantly diverged.
- Dynamic ddPCR trends outperformed static measures for reflecting clinical trajectory.
Methodological Strengths
- Prospective observational design with predefined serial sampling at days 0, 3, and 7.
- Multivariable Cox modeling and Kaplan–Meier survival analyses linking kinetics to outcomes.
Limitations
- Single-center cohort with ddPCR limited to four Gram-negative species; external validity may be constrained.
- No interventional algorithm tested; antimicrobial regimens were not standardized.
Future Directions: Expand ddPCR panels, integrate kinetics into decision algorithms, and test ddPCR-guided management in randomized trials across multiple centers.
OBJECTIVE: To investigate the relationship between the pathogen load kinetics detected by droplet digital polymerase chain reaction (ddPCR) and the prognosis of patients with suspected bloodstream infection (BSI). METHODS: A prospective observational study was conducted. Patients aged >18 years with suspected BSI admitted to intensive care unit department of Zhejiang Provincial People's Hospital from March 1, 2022 to October 31, 2023 were consecutively enrolled. Patients with blood ddPCR detection positive for pathogenic bacteria such as Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, or Pseudomonas aeruginosa were included. Demographics, clinical profile, vital signs, and comorbidities data of patients upon admission were collected. Blood ddPCR testing, laboratory tests, and disease severity scoring were performed on days 0, 3, and 7. Based on whether the follow-up ddPCR test at day 7 showed a ≥50% decrease in all pathogen load compared to admission, patients were divided into the pathogen load decrease group and pathogen load non-decrease group. Baseline characteristics and the dynamic changes in perfusion indicators, inflammation indicators, and disease severity scores between two groups were compared. The correlation between ddPCR detection of pathogen load and perfusion indicators, inflammation indicators, and disease severity scores were analyzed using Spearman test. The 28-day cumulative survival rate of pathogen load decrease group and pathogen load non-decrease group was analyzed using Kaplan-Meier survival curve. Patients were divided into the survival group and death group according to the 28-day prognosis, and the clinical data were compared between the two groups. Independent risk factors for 28-day mortality in patients with suspected BSI were identified using multivariate Cox proportional hazards regression models. RESULTS: A total of 189 suspected BSI patients with ddPCR positive for Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, or Pseudomonas aeruginosa infection were enrolled, of whom 121 underwent dynamic monitoring. Among these 121 patients, 82 showed a decrease in ddPCR pathogen load at day 7, while 39 did not. During the 28-day follow-up, 76 survived and 45 died, and the 28-day mortality was 37.2%. Compared to the pathogen load decrease group, the pathogen load non-decrease group had a higher proportion of patients receiving vasoactive drug support and mechanical ventilation, and a higher 28-day mortality (all P<0.05). In patients with suspected BSI, the ddPCR pathogen load on day 0 showed significant positive correlations with high-sensitivity C-reactive protein (hs-CRP), procalcitonin (PCT), blood lactate (Lac), Acute Physiology and Chronic Health Evaluation II (APACHE II), and Sequential Organ Failure Assessment (SOFA; r values were 0.150, 0.273, 0.370, 0.334, 0.311, respectively; all P<0.05). The Lac, hs-CRP, PCT and APACHE II in pathogen load decrease group decreased with time. However, hs-CRP and PCT did not decrease in pathogen load non-decrease group, and APACHE II and SOFA scores further increased. At day 7, compared to the pathogen load non-decrease group, the pathogen load decrease group showed significant reductions in hs-CRP, PCT, APACHE II and SOFA scores (all P<0.05); however, there was still no statistically significant difference in Lac between the two groups. Kaplan-Meier survival curve analysis showed that the 28-day cumulative survival rate of the pathogen load decrease group was significantly higher than that of the pathogen load non-decrease group (Log-rank test: χ CONCLUSIONS: Dynamic monitoring of pathogen load changes by ddPCR can reflect the prognosis of patients with suspected BSI, suggesting the role of ddPCR detection in therapeutic monitoring for patients with BSI.